Jorge Gomez has left his role as CFO of Moderna after two days on the job, the company announced Wednesday morning.
Gomez’s departure comes one day after his former employer, Dentsply Sirona, publicly disclosed it is conducting an internal investigation into certain financial reporting matters.
David Meline, who recently retired as Moderna’s CFO, will return to his old role effective immediately while the company reopens its search for a successor.
Gomez was hired as Moderna’s CFO in mid-April, joining the C-suite alongside Arpa Garay, who was hired as the company’s chief commercial officer last month.
The CFO shuffle came one week after Moderna released its latest earnings report, highlighted by $6.1 billion in revenue and a GAAP net income of $3.7 billion during Q1.
Tthe company recently filed for an emergency use authorization with the Food and Drug Administration for its COVID-19 vaccine for use in children under six years of age.